Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1054)
  3. Book Section (64)
  4. Review (63)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2692)
  2. Department of Medicine (2692)
  3. Hematologic Malignancies, Division of (2692)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (653)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (442)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (39)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (875)
  2. Journal of Clinical Oncology (275)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (940)
  2. American Society of Clinical Oncology (291)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2692)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma
    Journal Article

    Liu, Y.; Sardana, R.; Nemirovsky, D.; Frosina, D.; Jungbluth, A.; Johnson, W. T.; Vardhana, S.; Arcila, M.; Horwitz, S. M.; Derkach, A.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • A novel JAK2 fusion in T-cell prolymphocytic leukemia
    Journal Article

    Eren, O. C.; Stuver, R.; Zhou, T.; Zaidinski, M.; Moskowitz, A. J.; Horwitz, S. M.; Ewalt, M. D.; Zhang, Y.; Lim, M. S.
    Genes Chromosomes and Cancer (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: A propensity score–matched analysis
    Journal Article

    Driessen, J.; de Wit, F.; Herrera, A. F.; Zinzani, P. L.; LaCasce, A. S.; Cole, P. D.; Moskowitz, C. H.; García-Sanz, R.; Fuchs, M.; Müller, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
    Research Letter

    Zinzani, P. L.; Salles, G.; Moskowitz, A. J.; Santoro, A.; Mehta, A.; Barr, P. M.; Mehta-Shah, N.; Collins, G. P.; Ansell, S. M.; Brody, J. D.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas
    Journal Article

    Soumerai, J. D.; Diefenbach, C. S.; Jagadeesh, D.; Asch, A.; Kumar, A.; Tsai, M. L.; Jandl, T. A.; Lossos, I. S.; Kenkre, V. P.; Awan, F.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
    Research Letter

    Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • ASCT2-targeting antibody-drug conjugate medi7247 in adult patients with relapsed/refractory hematological malignancies: A first-in-human, phase 1 study
    Journal Article

    Maris, M.; Salles, G.; Kim, W. S.; Kim, T. M.; Lyons, R. M.; Arellano, M.; Karmali, R.; Schiller, G.; Cull, E.; Abboud, C. N.; more...
    Targeted Oncology (2024)

    Fulltext@MSK | Save
  • Failing forward in peripheral T-cell lymphoma
    Editorial

    Mehta-Shah, N.; Horwitz, S. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Journal Article

    Bantilan, K. S.; Smith, A. N.; Maurer, M. J.; Teruya-Feldstein, J.; Matasar, M. J.; Moskowitz, A. J.; Straus, D. J.; Noy, A.; Palomba, M. L.; Horwitz, S. M.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • A comparison of 3-year follow-up of ZUMA-5 (axicabtagene ciloleucel) with SCHOLAR-5 in relapsed/refractory follicular lymphoma
    Editorial

    Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Owen, J.; Kanters, S.; Bobillo, S.; Ribiero, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save